| 摘要 |
This invention comprises novel carbocyclic compounds of formula I (wherein A, Z, R<1><1> and R<1><2> are defined in the specification) derived from acylsulfonamide derivatives of alpha -carbocyclyltoluic acids wherein said compounds of formula I antagonize the actions of one or more of the arachidonic acid metabolites known as leukotrienes. The invention also provides pharmaceutically acceptable salts of the formula I compounds; pharmaceutical compositions containing the formula I compound, or their salts, for use in the treatment of, for example, allergic or inflammatory diseases, or endotoxic or traumatic shock conditions; and processes for the manufacture of the formula I compounds, as well as intermediates for use in such manufacture. |
